ALB and infection: In a sub-analysis of the ATTIRE study (Albumin infusion to prevent infection in chronic liver failure), NSBB-treated patients and controls were investigated to find out whether the use of NSBBs was associated with higher hospitalization rates due to infection, more frequent nosocomial infections, higher rates of liver-related complications, or a worse prognosis.